Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!
What is the Expected Growth Rate of the Peripheral Arterial Disease Market from 2024 to 2033?
The peripheral arterial disease market has shown strong growth in recent years. It is expected to increase from $4 billion in 2023 to $4.36 billion in 2024, at a CAGR of 9.1%. Growth drivers include the development of innovative medical devices, gene therapy and regenerative medicine, pharmacogenomics, and the rise of digital health and remote monitoring.
The peripheral arterial disease market is projected to grow to $6.05 billion by 2028 at a CAGR of 8.5%. The growth is attributed to interdisciplinary care teams, minimally invasive interventions, and lifestyle prescriptions. Trends include vascular tele-rehabilitation, multimodal pain management, advancements in wound care, and public health campaigns.
Claim Your Free Sample of the Global Peripheral Arterial Disease Market Report Today!
https://www.thebusinessresearchcompany.com/sample.aspx?id=12999&type=smp
The increasing prevalence of cardiac diseases is expected to fuel the growth of the peripheral arterial disease market. Cardiac diseases, which impact the heart and blood vessels, are a significant factor in peripheral arterial disease (PAD), which improves blood flow and reduces cardiovascular risk. The Centers for Disease Control and Prevention reported that cardiovascular disease-related deaths reached 695,547 in 2021. Additionally, the American College of Cardiology predicts that ischemic heart disease cases will increase by 30.7% by 2025. The rise in cardiac diseases is driving the PAD market.
1) By Treatment Type: Devices, Catheters, Drugs, Other Types
2) By Route of Administration: Oral, Parenteral, Other Route of Administrations
3) By End User: Hospitals, Specialty Clinics, Others End-Users
Major companies in the peripheral arterial disease market are focused on developing drugs and solutions to improve patient outcomes. For instance, in August 2021, The Janssen Pharmaceutical Companies, a Belgium-based company, received FDA approval for an expanded indication for XARELTO (rivaroxaban), the first therapy for both coronary artery disease and peripheral artery disease (PAD). This drug is also recommended for patients with acute limb ischemia, amputation, ischemic stroke, and myocardial infarction.
Order Now for Fast Delivery of Your Peripheral Arterial Disease Market Report!
https://www.thebusinessresearchcompany.com/report/peripheral-arterial-disease-global-market-report
North America was the largest region in the adrenal cancer diagnostics market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adrenal cancer diagnostics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
The Peripheral Arterial Disease Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the peripheral arterial disease market, its market share, and analyzes key competitors along with their market positions.
The Table Of Content For The Peripheral Arterial Disease Market Include
1. Peripheral Arterial Disease Market Executive Summary
2. Peripheral Arterial Disease Market Segments
3. Peripheral Arterial Disease Market Size And Template Market Growth Rate
4. Key Peripheral Arterial Disease Market Trends
5. Major Peripheral Arterial Disease Market Drivers
……
25. Key Mergers And Acquisitions In The Peripheral Arterial Disease Market
26. Top Peripheral Arterial Disease Companies
27. Peripheral Arterial Disease Market Opportunities And Strategies
28. Peripheral Arterial Disease Market, Conclusions And Recommendations
29. Appendix
Discover Related Reports by The Business Research Company:
Analysis of Blood Transfusion Diagnostics Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-transfusion-diagnostics-global-market-report
Patient Blood Management Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/patient-blood-management-global-market-report
Anemia and Other Blood Disorder Drugs Global Market Report 2024
Learn More About The Business Research Company
The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on: